z-logo
open-access-imgOpen Access
Changing epidemiology of candidaemia in Australia
Author(s) -
Belinda Chapman,
Monica A. Slavin,
Debbie Marriott,
Catriona Halliday,
Sarah Kidd,
Ian Arthur,
Narin Bak,
Christopher H. Heath,
Karina Kennedy,
C. Orla Morrissey,
Tania C. Sorrell,
Sebastian van Hal,
Caitlin Keighley,
Emma Goeman,
Neil Underwood,
Krispin Hajkowicz,
Ann Hofmeyr,
Michael Leung,
Nenad Macesic,
Jeannie Botes,
Christopher C. Blyth,
Louise Cooley,
C. R. Robert George,
Pankaja Kalukottege,
Alison Kesson,
Brendan McMullan,
Rob Baird,
Jennifer Robson,
Tony M. Korman,
Stella Pendle,
Kerry Weeks,
Sharon Chen
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw422
Subject(s) - anidulafungin , fluconazole , micafungin , caspofungin , candida glabrata , candida tropicalis , voriconazole , echinocandin , microbiology and biotechnology , candida parapsilosis , biology , posaconazole , candida albicans , fungemia , antifungal
Knowledge of contemporary epidemiology of candidaemia is essential. We aimed to identify changes since 2004 in incidence, species epidemiology and antifungal susceptibilities of Candida spp. causing candidaemia in Australia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom